Migraineurs' perceptions of and interactions with pharmacists: A qualitative study

International Journal of Pharmacy Practice

Volumn 16, Issue 6, 2008, Pages 357-363

  Skomo, Monica L ^a,b   Desselle, Shane P ^a   Shah, Neel ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID PLUS BUTALBITAL PLUS CAFFEINE; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; EXCEDRIN; IBUPROFEN; NON PRESCRIPTION DRUG; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CLINICAL ARTICLE; COMMUNICATION SKILL; CONTROLLED STUDY; COPING BEHAVIOR; DOCTOR PATIENT RELATION; FAMILY LIFE; FEMALE; HEADACHE; HUMAN; INTERVIEW; MALE; MIGRAINE; NONVERBAL COMMUNICATION; PATIENT ATTITUDE; PHARMACEUTICAL CARE; PHARMACIST; PHENOMENOLOGY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; QUALITATIVE RESEARCH; SOCIAL SUPPORT; UNITED STATES;

EID: 57049156672     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/ijpp.16.6.0004     Document Type: Article

References (36)

1. Lipton RB, Stewart W, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 2001;41: 646-57.
2. Ruiz de Velasco I, Gonzalez N, Etxeberria Y, Garcia-Monco JC. Quality of life in migraine patients: a qualitative study. Cephalalgia 2003;23:892-900.
3. Kryst S, Scherl E. A population-based survey of the social and personal impact of headache. Headache 1994;34:344-50.
4. Brandes J. Global trends in migraine care: results from the MAZE survey. CNS Drugs 2002;16(Suppl. 1):13-18.
5. Lipton RB, Stewart W, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache 1998;38:87-96.
6. Lipton RB, Diamond S, Reed M, Diamond M, Stewart W. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001;41:638-45.
7. Schreiber C, Hutchinson S, Webster C, Ames M, Richardson M, Powers C. Prevalence of migraine in patients with a history of self-reported or physician-diagaosed "sinus" headache. Arch Intern Med 2004; 164:1769-72.
8. Diamond M. The role of concomitant headache types and non-headache co-morbidities in the underdiagnosis of migraine. Neurology 2002;58(Suppl. 6):S3-9.
9. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy M. Migraine and chronic daily headache management: a qualitative study of patients' perceptions. Scand J Caring Sci 2004;18:294-303.
10. MacGregor EA, Brandes J, Eikermann A. Migraine prevalence and treatment patterns: the global migraine and zolmitriptan evaluation survey. Headache 2003;43:19-26.
11. MacGregor EA, Brandes J, Gendolla A. Giammarco R. Migraine treatment strategries: the global Migraine and Zolmitriptan Evaluation (MAZE) survey - phase IV. Curr Med Res Opin 2004;20:1777-83.
12. Lipton RB, Stewart WF, Stone AM, Lainez MJ, Sawyer JP. The Disability in Strategies of Care (DISC) study. JAMA 2000;284:2599-605.
13. OTC products: 200 survey of pharmacist recommendations. Pharmacy Times 2004;(Suppl.):1-44.
14. Worley M, Schommer J. Pharmacist-patient relationships: factors influencing quality and commitment. J Soc Adm Pharm 1999;16:157-73.
15. Cottrell C, Drew J, Waller S, Holroyd K, Brose J, O'Donnell F. Perceptions and needs of patients with migraine: a focus group study. J Fam Pract 2002;51(2):142-7.
16. Powell R, Single H. Methodology matters-V: focus groups. Int J Qual Health Care 1996;8:499-504.
17. Sim J. Collecting and analyzing qualitative data: issues raised by focus groups. J Adv Nuts 1998;28:345-52.
18. Lipton RB, Dodick D, Sadovsky R et al. A self-administered screener for migraine in primary care: the ID Migraine(TM) validation study. Neurology 2003;61(3):375-82.
19. Headache Classification Committee of the International Headache Society: classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988;8(Suppl. 7):1-96.
20. Leone M, Filippine G, D'Amico D, Farinotti M, Bussone G. Assessment of International Headache Society diagnostic criteria: a reliability study. Cephalalgia 1994;14(4):280-4.
21. Patton MQ. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage Publications; 2002.
22. Peters M, Huijer Abu-Saad H, Vydelingum V, Dowson A, Murphy A Patients' decision-making for migraine and chronic daily headache management: a qualitative study. Cephalalgia 2003;23:833-41.
23. Strickland O, Giger J, Nelson M, Davis C. The relationships among stress, coping, social support, and weight class in premenopausal African American women at risk for coronary heart disease. J Cardiovasc Nuts 2007;22:272-8.
24. Lanteri-Minet M, Massiou H, Nachit-Ouinekh F et al. The GR1M200 study of migraine consultation in France I. Determinants of consultation for migraine headache in France, Cephalalgia 2007 27(12):1386-97
25. Skomo ML, Desselle SP, Berdine HJ. Factors influencing migraineur consulting behavior in a university population. Headache 2006;46:742-9.
26. Lipton RB, Scher AI, Bigal ME et al. Patterns of health care utilization for migraine in England and in the United States, Neurology 2003;60:441-8.
27. Terwindt GM, Ferrari MD, Tijhuis M, Goenen SM, Picavet HS, Launer LJ. The impact of migraine on quality of life in the general population: the GEM study. Neurology 2000;55:624-9.
28. Stewart WF, Shechter A, Lipton RB. Migraine heterogeneity: disability, pain intensity, and attack frequency and duration. Neurology 1994;44(6 Suppl. 4):S24-39.
29. Worley M, Schommer J, Brown L et al. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script? Res Social Adm Pharm 2007;3(1):47-69.
30. Berringer R, Shibley M, Cary C, Pugh C, Powers P, Rafi J. Outcomes of a community pharmacy-based diabetes monitoring program. J Am Phann Assoc 1999;30:238-43.
31. Cranor CE, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc 2003;43:149-59.
32. Zillich A, Sutherland J, Kumbera P, Carter B. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). J Gen lntern Med 2005;20:1091-6.
33. Osterhaus J, Dedhiya S, Ernst M. Osterhaus M. Mehta SS, Townsend R. Health outcomes assessment in community pharmacy practices: a feasibility project. Arthritis Rheum 2002;47(2):124-31.
34. Nau DP, Ried LD, Lipowski EE, Kimberlin C, Pendergast J. A perceived value model for explaining patients' intentions to continue use of pharmaceutical care services. J Pharm Market Manage 2001;14(1):63-80.
35. Angelo L, Ferreri S. Assessment of workflow redesign in community pharmacy. J Am Pharm Assoc 2005;45(2):145-50.
36. Schommer J, Wiederholt J. A field investigation of participant and environment effects on pharmacist-patient communication in community pharmacies. Med Care 1995;33:567-84.